USE OF A PHARMACEUTICAL COMPOSITION COMPRISING IMMUNE-CHECKPOINT INHIBITORS IN THE… Application EA-039307-B1 Eurasian Patent Organisation 12 Jan 2022
BIOMARKER FOR OUTCOME IN AML PATIENTS Application WO-2018162404-A1 World Intellectual Property Organisation (WIPO) 13 Sep 2018